SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?


To: SKARLOEY who wrote (766)3/22/1998 4:14:00 AM
From: Ted Zeilstra  Read Replies (2) | Respond to of 1055
 
While I agree with the "potential" for THRX, maybe we should do a reality check. This stock has basically doubled in about 3 months. That trend cannot continue given current (or currently projected) revenues and earnings. At some point, this stock will a) level off, b)continue to rise, or c) fall - in any event, the eventual result will finally put it at a "fair market value".

I suspect that shortly after the split, THRX will "settle down" and a lot of the volatility will disappear. That's when it will find it's fair market value and the momentum players will disappear. The stock will then trade based on fundamentals.

Look at Friday's close of both THRX and INIS. One up, the other down. Could it be that people are already bailing from THRX and moving into INIS before THRX splits in hopes of catching a similar wave on INIS? INIS has doubled in less than 3 months, so I'm not really sure that's what's happening.

Just food for thought.